Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is characterized by a poor prognosis, with a progressive decline in lung function and considerable variability in the disease’s natural history. Besides lung transplantation (LTx), the only available treatments are anti-fibrosing drugs, which have show...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzetti, Gian Marco, Hosein, Karishma, Cecchini, Matthew J., Kwan, Keith, Abdelrazek, Mohamed, Zompatori, Maurizio, Rogliani, Paola, Mura, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645123/
https://www.ncbi.nlm.nih.gov/pubmed/34863146
http://dx.doi.org/10.1186/s12890-021-01753-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645123/
https://www.ncbi.nlm.nih.gov/pubmed/34863146
http://dx.doi.org/10.1186/s12890-021-01753-7

Ejemplares similares